The Master of Science (M.Sc.) in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf) in Bavaria, Germany - is accepting applications for entry in October 2019.

IMS MAXIMS and Secure Exchange Solutions have announced a partnership to offer mobile, secure and cost-effective provider-to-provider and provider-to-patient communications to NHS organisations, GP practices and patients.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology today announced the results of the Advancing Care Coordination & Telehealth Deployment at Scale (ACT@Scale) Program during the 19th annual International Conference on Integrated Care in San Sebastian, Spain.

The London-wide service by Coordinate My Care powered by InterSystems HealthShare® has been highly commended in the medical software, systems and technology category at this year’s HSJ Partnership Awards, which celebrated successes in the NHS.

An alliance between Highland Marketing and Experiential HealthTech will be announced at this year's Digital Health Rewired, with both companies exhibiting from stand B14. Highland Marketing is a full-service marketing, content and PR agency, specialising in health technology, while Experiential HealthTech is an independent consultancy providing strategic analysis and advice to companies operating in health and the wider healthcare ecosystem.

This year's Moore Blatch Silicon Cup has been launched and is now open for IT companies to enter. The event takes place over 26 - 27 September on the Isle of Wight, near Cowes. The largest sailing regatta for the IT industry started the countdown to this year’s event with a drinks reception in the City of London - which included a cheque presentation to its three nominated charities.

As a pioneer when it comes to collaborating with digital health start-ups, Bayer is now taking the next step. Instead of one-off startup programs, it is now focusing on collaborating in specific digital health focus areas, e.g. digital therapeutics, AI for drug discovery, and patient engagement platforms to name a few. To do this, Bayer is combining the G4A programs and concentrating on longer-term collaborations and investments.